Premium
Effect of flutamide and two novel synthetic steroids on GABA, glutamine and some oxidative stress markers in rat brain and prostate
Author(s) -
Calderón Guzmán D.,
Bratoeff E.,
Ramírez López E.,
Hernández García E.,
Pierdant Rioja F.,
Osnaya Brizuela N.,
Trujillo Jiménez F.,
Barragán Mejía G.,
Juárez Olguín H.,
Santamaría del Ángel D.
Publication year - 2011
Publication title -
andrologia
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.633
H-Index - 59
eISSN - 1439-0272
pISSN - 0303-4569
DOI - 10.1111/j.1439-0272.2010.01051.x
Subject(s) - flutamide , tbars , endocrinology , medicine , oxidative stress , glutathione , glutamine , testosterone (patch) , chemistry , lipid peroxidation , pharmacology , biochemistry , amino acid , prostate cancer , androgen receptor , enzyme , cancer
Summary Flutamide is a steroid used to treat androgen‐dependent disorders and as antiepileptic, but it induces a number of non‐desirable side effects. This work was aimed at assaying the effect of flutamide and two novel synthetic steroids on the levels of GABA, glutamine and oxidative stress markers. Male Wistar rats (weight 180 g) received a single diazepam dose (5 mg/kg) 30 min prior to sacrifice (group A). Group B, flutamide; group C, 16β‐methyl‐17α‐benzoyloxypregnen‐4‐en‐3,20‐dione; group D, estrone‐3‐hemisuccinate; group E, testosterone; group F, progesterone; all administered intraperitoneally at 10 mg/kg, daily for 3 days. Brain and prostate were obtained to assess lipid peroxidation (TBARS), Na + , K + ATPase activity, reduced glutathione (GSH), γ‐amino butiric acid (GABA), glutamine and serotonin (5‐HT) concentrations through spectrophotometry, fluorescence and HPLC. GABA levels increased and glutamine decreased in group A ( P < 0.05). Total ATPase activity increased in group F and TBARS decreased in group B ( P < 0.05). GSH decreased in A, B and C groups. 5‐HT increased in group A and the prostate weight was increased in group E. The conclusion is that 16β‐methyl‐17α‐benzoyloxypregnen‐4‐en‐3,20‐dione may be considered novel and promising to treat androgen‐dependent diseases and epilepsy, since it showed an antioxidant effect and seemed to impair the GABAergic and serotonergic metabolism.